Validating RNAseq-Signatures of Vorinostat (VOR) Sensitivity and Resistance in Patients with Newly Diagnosed Glioblastoma (GBM) Treated with VOR, Temozolomide and Radiation Therapy From Alliance N0874/ABTC-0902. Anderson, S. Keith , Miller, C. Ryan , Sarkaria, Jann N. ... - ASCO - J. Clin. Oncol. - 2016 Abstract - Secondary - Primary - Neuro-Onc - N0874 , ABTC-0902
Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177 Brown, Paul D. , Krishnan, Sunil , Sarkaria, Jann N. , Wu, Wenting ... - - J Clin Oncol - 2008 Manuscript - Primary - Primary - Neuro-Onc - N0177
Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02 Galanis, Evanthia , Anderson, S Keith , Miller, C Ryan ... - - Neuro-oncology - 2018 Manuscript - Primary - Primary - Neuro-Onc - N0874
Phase II trial of vorinostat (VOR) combined with temozolomide (TMZ) and radiation therapy (RT) for newly diagnosed glioblastoma (GBM) (Alliance N0874/ABTC-0902) Galanis, Evanthia , Anderson, S. Keith , Miller, C. Ryan ... - ASCO - J. Clin. Oncol. - 2014 Abstract - Primary - Primary - Neuro-Onc - N0874
Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North Central Cancer Treatment Group study N0272 (Alliance/NCCTG) Jaeckle, Kurt A. , Anderson, S K. , Twohy, Erin L. , Dixon, Jesse G. ... - - J. Neurooncol. - 2019 Manuscript - Primary - Primary - Neuro-Onc - N0272
A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K Ma, Daniel J. , Galanis, Evanthia , Anderson, S. Keith ... - - Neuro-oncology - 2015 Manuscript - Primary - Long-Term-Followup - Neuro-Onc - N057K
Combination of temsirolimus (CCI-779) with chemo-radiation in newly diagnosed GBM (NCCTG trial N027D) is associated with increased infectious risks1 Sarkaria, Jann N. , Galanis, Eva , Wu, Wenting , Dietz, Allan B. ... - - Clin Cancer Res - 2010 Manuscript - Primary - Primary - Neuro-Onc - N027D
NCCTG Phase I Trial N057K of Everolimus (RAD001) and Temozolomide in Combination with Radiation Therapy in Newly Diagnosed Glioblastoma Multiforme Patients1 Sarkaria, Jann N. , Galanis, Evanthia , Wu, Wenting ... - - Int J Radiat Oncol Biol Phys - 2011 Manuscript - Primary - Primary - Neuro-Onc - N057K
Phase I/II Trial of Temsirolimus and Sorafenib in Treatment of Patients with Recurrent Glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572 Schiff, David , Jaeckle, Kurt A , Anderson, S. Keith ... - - Cancer - 2018 Manuscript - Primary - Primary - Neuro-Onc - N0572